ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma

Abstract

Metalloproteinase activities of a disintegrin and metalloproteinase 17 (ADAM17), amphiregulin (AREG), extracellular matrix metalloproteinase inducer (EMMPRIN), and matrix metalloproteinases (MMPs) are involved in tumor biology. In patients with uterine cervical carcinoma, the expression and prognostic significance of ADAM17 remain to be fully elucidated… (More)
DOI: 10.1007/s13277-014-1990-1

Topics

7 Figures and Tables

Statistics

020406020162017
Citations per Year

Citation Velocity: 11

Averaging 11 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Xu2014ADAM17IA, title={ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma}, author={Qin Xu and Mingang Ying and Guilin Chen and Ang Lin and Yunqing Xie and Noriyuki Ohara and Dongmei Zhou}, journal={Tumor Biology}, year={2014}, volume={35}, pages={7575-7586} }